Skip to Content

China Health Industries Holdings Inc - Stock Quote CHHE

Rating as of

Morningstar's China Health Industries Holdings Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - CHHE

China Health Industries Holdings Inc's Company Profile

Business Description

China Health Industries Holdings Inc operates in the health product industry. It is engaged in the manufacturing, marketing, and distribution of health food products. The company segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment. HLJ Huimeijia business segment engages in the manufacture and distribution of tincture, ointments, rubber paste, topical solution, suppositories, liniment, enemas, and oral liquids.

3199-1 Longxiang Road, Songbei District
Harbin, 150028, China, People's Republic of
T +86 45188100688
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2022
Fiscal Year End Jun 30, 2022
Stock Type Distressed
Employees 68